Market Intelligence Ecosystem
Brooks Laboratories Ltd is a pharmaceutical contract manufacturing company. The company has manufacturing facilities in Baddi Himachal Pradesh and Vadodara Gujarat. Both
Brooks Laboratories Ltd is a pharmaceutical contract manufacturing company. The company has manufacturing facilities in Baddi Himachal Pradesh and Vadodara Gujarat. Both
Key highlights from JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) Q2 FY23 Earnings Concall Management Update: [00:06:28] JBCHEPHARM said that in domestic markets
Key highlights from Biocon Limited (BIOCON) Q2 FY23 Earnings Concall Q&A Highlights: [00:23:49] Prakash Agarwal of Axis Capital asked about the mezzanine
Aarti Industries Ltd (NSE:AARTIIND) Q2 FY23 Earnings Concall dated Nov. 15, 2022 Corporate Participants: Rajendra V. Gogri -- Chairman and Managing Director
JB Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Q2 FY23 Earnings Concall dated Nov. 14, 2022 Corporate Participants: Jason D'Souza -- Vice President of Investor Relations Nikhil Chopra -- Chief
Aurobindo Pharma Limited (NSE: AUROPHARMA) Q2 FY23 Earnings Concall dated Nov. 13, 2022 Corporate Participants: Deepti Thakur -- Investor Relations Santhanam Subramanian -- Chief Financial Officer
Gufic Biosciences Limited (NSE:GUFICBIO) Q2 FY23 Earnings Concall dated Nov.13, 2022 Corporate Participants: Ami Naresh Shah -- Company Secretary and Compliance Officer Avik Das -- Investor
Alkem Laboratories Ltd (NSE:ALKEM) Q2 FY23 Earnings Concall dated Nov. 11, 2022 Corporate Participants: Amit Kumar Khandelia -- Assistant Vice President, Finance
Supriya Lifescience Ltd (NSE:SUPRIYA) Q2 FY23 Earnings Concall dated Nov. 11, 2022 Corporate Participants: Rasika Sawant -- Investor Relation Partner Satish Wagh
NATCO Pharma Limited (NSE:NATCOPHARM) Q2 FY22 Earnings Concall dated Nov. 11, 2022 Corporate Participants: Rajeev Nannapaneni -- Director and Chief Executive Officer Rajesh Chebiyam -- Executive
https://youtu.be/-5pgj3qU44c Key highlights from Sequent Scientific Limited (SEQUENT) Q2 FY23 Earnings Concall Q&A Highlights: [00:17:40] Rishab Jain asked about Tineta Pharma acquisition,
https://youtu.be/lAaNZKEvjOc Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q2 FY23 Earnings Concall Q&A Highlights: [00:16:43] Rahul Agarwal with Incred Capital enquired
Shares of Lupin gained as much as 8 percent in early trading on Thursday after the company returned to profitability during the
Lupin Ltd (NSE:LUPIN) Q2 FY23 Earnings Concall dated Nov. 10, 2022 Corporate Participants: Vinita Gupta -- Chief Executive Officer Ramesh Swaminathan --
Key highlights from Cipla Limited (CIPLA) Q2 FY23 Earnings Concall Management Update: [00:02:21] CIPLA reported the highest quarterly revenue historically of INR5,829
Solara Active Pharma Sciences Limited (NSE:SOLARA) Q2 FY23 Earnings Concall dated Nov. 09, 2022 Corporate Participants: Abhishek Singhal -- Investor Relations Jithesh Devendra -- Managing Director
Sequent Scientific Limited (NSE:SEQUENT) Q2 FY23 Earnings Concall dated Nov. 08, 2022 Corporate Participants: Abhishek Singhal -- Head of Investor Relations Rajaram
https://youtu.be/e1-tljnhSVM Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q2 FY23 Earnings Concall Management Update: [00:06:48] DIVISLAB stated that though global logistics scenario
Rossari Biotech Ltd (NSE:ROSSARI) Q2 FY23 Earnings Concall dated Nov. 07, 2022 Corporate Participants: Anoop Poojari -- Client Manager Edward Menezes --
Poly Medicure Limited (NSE:POLYMED) Q2 FY23 Earnings Concall dated Nov. 07, 2022 Corporate Participants: Himanshu Baid -- Managing Director Naresh Vijayvergiya --